25^th World Biotechnology Congress

The European biotech sector had a jolting past. Today, but it have reached a record momentum and flourishing like ne'er before. Stock exchanges, like Euronext, support Biotech corporations and have contributed for the most part to the record high we tend to see these days.

The global monetary crisis hit Europe in 2008. Like a tsunami, it torus through the biotech sector, giving up the detritus of shattered corporations and leading to widespread cost-cutting with workers being ordered off and analysis shelved. Nearly a decade later, the European biotech sector is flourishing once more and has reached a momentum that was quite unpredictable within the aftermath of 2008. The global market for microbiology technology, equipment and consumables market reached $9.8 billion revenue in 2015. The market should reach nearly $12.3 billion by 2020, increasing at a compound annual growth rate (CAGR) of 4.6% from 2015 to 2020.